Area of research
Immunology · Biotechnology
Research interest
Research interests include T-cell and B-cell Immunology, Immune Cell Function and Interaction, Immunotherapy and Immune Responses, and Cancer Research and Treatments.
Host Plasma Microenvironment in Immunometabolically Impaired HIV Infection Leads to Dysregulated Monocyte Function and Synaptic Transmission <i>Ex Vivo</i>
RORγt+ c-Maf+ Vγ4+ γδ T cells are generated in the adult thymus but do not reach the periphery
Microbiota-Induced Type I Interferons Instruct a Poised Basal State of Dendritic Cells
<p>Functional design of pH-responsive folate-targeted polymer-coated gold nanoparticles for drug delivery and in vivo therapy in breast cancer</p>
<p>Functional design of pH-responsive folate-targeted polymer-coated gold nanoparticles for drug delivery and in vivo therapy in breast cancer</p>
miR-181a/b-1 controls thymic selection of Treg cells and tunes their suppressive capacity
The immunogenic potential of bacterial flagella for <i>Salmonella</i>‐mediated tumor therapy
Regulation of Flagellum Biosynthesis in Response to Cell Envelope Stress in <i>Salmonella enterica</i> Serovar Typhimurium
Importance of flagella in acute and chronic <i>Pseudomonas aeruginosa</i> infections
RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injury
Essential role for the transcription factor Bhlhe41 in regulating the development, self-renewal and BCR repertoire of B-1a cells
Engineered <i>Salmonella enterica</i> serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy
A New RNA-Based Adjuvant Enhances Virus-Specific Vaccine Responses by Locally Triggering TLR- and RLH-Dependent Effects
cGAS-STING-TBK1-IRF3/7 induced interferon-β contributes to the clearing of non tuberculous mycobacterial infection in mice
Therapeutic benefit of<i>Salmonella</i>attributed to LPS and TNF-α is exhaustible and dictated by tumor susceptibility
Tumour‐targeting bacteria‐based cancer therapies for increased specificity and improved outcome
Local application of bacteria improves safety of <i>Salmonella</i> -mediated tumor therapy and retains advantages of systemic infection
Interleukin‐23–Dependent γ/δ T Cells Produce Interleukin‐17 and Accumulate in the Enthesis, Aortic Valve, and Ciliary Body in Mice
Bacteria in Cancer Therapy: Renaissance of an Old Concept
Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses
<i>aroA</i> -Deficient Salmonella enterica Serovar Typhimurium Is More Than a Metabolically Attenuated Mutant
Growing tumors induce a local STING dependent Type I IFN response in dendritic cells
Optimizing<i>Salmonella enterica</i>serovar Typhimurium for bacteria-mediated tumor therapy
Topical imiquimod yields systemic effects due to unintended oral uptake
Therapy of solid tumors using probiotic Symbioflor-2 - restraints and potential
Type <scp>I</scp><scp>IFN</scp>s induce anti‐tumor polarization of tumor associated neutrophils in mice and human
The LasB Elastase of Pseudomonas aeruginosa Acts in Concert with Alkaline Protease AprA To Prevent Flagellin-Mediated Immune Recognition
Active suppression of intestinal CD4+TCRαβ+ T-lymphocyte maturation during the postnatal period
A clonotypic Vγ4Jγ1/Vδ5Dδ2Jδ1 innate γδ T-cell population restricted to the CCR6+CD27− subset
Norovirus Triggered Microbiota-driven Mucosal Inflammation in Interleukin 10-deficient Mice